or Try an Advanced Search...

    Treatment Of Hypertension Stocks List

    Symbol Grade Name % Change
    MLYS D Mineralys Therapeutics, Inc. -1.07
    RDHL F Redhill Biopharma Ltd. -0.16
    BMY F Bristol-Myers Squibb Company 0.66
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Hypertension Medicine Abdominal Pain Antibiotics Atrial Fibrillation Autoimmune Disease Bacteria Biopharmaceutical Products Cancer Treatment Cardiovascular Disease Chronic Myeloid Leukemia Clinic Clinical Medicine Crohn's Disease Depressive Disorder Diabetes Diabetic Nephropathy Dysfunction Dystrophy

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hypertension stocks.

    Symbol Grade Name Weight
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 6.67
    MEDX F Horizon Kinetics Medical ETF 5.43
    WBIY D WBI Power Factor High Dividend ETF 4.72
    PPH C Market Vectors Pharmaceutical ETF 4.25
    XPH D SPDR S&P Pharmaceuticals ETF 4.05
    View all Treatment Of Hypertension ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare PPH to XPH Compare WBIY to PPH

        Treatment Of Hypertension Stocks Recent News

        Date Stock Title
        May 4 BMY Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago
        May 3 BMY Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
        May 3 BMY If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
        May 3 BMY The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
        May 3 BMY Bristol-Myers Squibb: A Lost Decade?
        May 2 BMY Schrodinger gets rights to cancer drug candidate back from Bristol
        May 2 BMY Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
        May 2 MLYS Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
        May 1 BMY Editas, Bristol Myers extend T cell therapy collaboration
        May 1 BMY Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
        Apr 30 BMY Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
        Apr 30 BMY J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations
        Apr 30 BMY Bristol Myers Squibb: Tough Times Continue
        Apr 29 BMY J&J, Bristol Myers lose challenges to US drug price negotiation program
        Apr 29 BMY Bristol Myers, Repertoire to develop tolerizing vaccines in multi-year pact
        Apr 29 BMY Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
        Apr 29 BMY Repertoire pivot pays dividends with Bristol Myers deal
        Apr 29 BMY Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 28 BMY Last Week's Worst-Performing Stocks: Are These 10 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Hypertension Medicine Abdominal Pain Antibiotics Atrial Fibrillation Autoimmune Disease Bacteria Biopharmaceutical Products Cancer Treatment Cardiovascular Disease Chronic Myeloid Leukemia Clinic Clinical Medicine Crohn's Disease Depressive Disorder Diabetes Diabetic Nephropathy Dysfunction Dystrophy
        Treatment Of Hypertension

        Treatment of hypertension typically involves lifestyle modifications such as reducing salt intake, increasing physical activity, and following a healthy diet. In addition, medications such as diuretics, beta-blockers, ACE inhibitors, and calcium channel blockers may be prescribed to help lower blood pressure.

        Browse All Tags